4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0000950170-24-038658
Chief Financial Officer sold 348 shares at $7.70 ($2,680)
From the SEC's structured data for this filing
Trades in this filing
Catinazzo Thomas · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-27 | Sale : show line 1 in the form | −348 | $7.70 | $2,680 | 341,498 | D |
| Open-market sales · 348 sh · avg $7.70 · $2,680 | ||||||
Loading xslF345X05/ownership.xml…